Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent
1988-11-01
1990-09-25
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
424 854, A61K 3766
Patent
active
049592106
ABSTRACT:
Condylomata Acuminata infections (anogenital warts) are treated in infected patients by administering liquid nitrogen and immediately thereafter beginning administering recombinant DNA human alpha interferon thrice a week for three weeks.
The interferon exemplified is recombinant DNA human interferon alfa-2b in which 1.0.times.10.sup.6 International Units are administered by injection to each lesion.
The liquid nitrogen is the cryosurgical agent exemplified and it is topically administered to each lesion by conventional means.
REFERENCES:
patent: 4286690 (1981-09-01), Pestka et al.
patent: 4503035 (1985-03-01), Pestka et al.
Ghosh, Britain Journal of Venereal Diseases, vol. 53, pp. 49-53, 1977.
Silva et al., J. Am. Acad. & Dermatology, vol. 13, 1985, pp. 457-463.
Eron et al., New Eng. J. Med., vol. 315, pp. 1059-1064, 1986.
Ferenczy et al., The NEJM 313, 784-788 (1985).
Rubenstein, Biochem. Biophys. Acta 695, 5-16 (1982).
Nagata et al., Nature 284, 316-320 (1980).
Smiles et al., The Biology of the Interferon System 1986, Cantell et al., Editor, Dordrecht, Martinus Mijhoff Publishers, 493-501 (1987).
Friedman-Kien et al., JAMA 259, 533-538 (1988).
Gall et al., Obstet Gynecol 67, 643 (1986).
Peets Edwin A.
Smiles Kenneth A.
Tanner Daniel J.
Hazel Blondel
Hoffman Thomas D.
Rosen Gerald S.
Schering Corporation
LandOfFree
Treatment of genital warts with a combination of liquid nitrogen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of genital warts with a combination of liquid nitrogen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of genital warts with a combination of liquid nitrogen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-328143